Dr. Reddy's Laboratories Ltd Common Stock (RDY)

SG&A Expense Growth

2.83%

Quarterly · Period ending:

RDY logo

RDY SG&A Expense Growth

Latest reported2.83%
RDY Quarterly SG&A Growth (QoQ) (0.00% → 2.83%)
High-resolution chart · PNG

RDY sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Dr. Reddy's Laboratories Ltd Common Stock SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
2.827%
4.7401%
1.8233%
14.0417%
-3.6333%
-0.2571%
4.8246%
1.3926%
10.8175%
1.226%
8,797.8376%
0%
-100%
-98.7834%
8,565.6368%
-98.6607%
7,337.1959%
-98.6483%
7,058.2572%
-98.569%
7,531.7281%
0%
-100%
-98.7742%
5.0012%
7,464.1095%
-99.0404%
39.0551%
-2.5129%
2.8249%
-2.7158%
2.1973%
0.3232%
0.1577%
9.2096%
-6.2144%
7.1995%
-3.2449%
-3.6776%
-4.1517%
5.6052%
-3.3807%
8.8714%
0.7746%
8.8375%
-9.5866%
4.4786%
-0.0562%
3.6092%
-1.2929%
7.2514%
10.7118%
0.8255%
1.7618%
6.9637%
-3.1896%
14.6875%
-6.0164%
6.4016%
6.8394%
10.2497%
-3.8751%
11.6678%
4.1226%
-5.6779%
7.0153%
1.7613%
-9.9544%
12.5522%
-2.1553%
1.8198%
12.5119%
10.1624%
13.3273%
5.5764%
13.625%
-8.7848%
-4.8278%
-1.1345%
9.0403%
44.7787%
14.51%
15.6592%
-10.6289%
-7.7094%
34.0724%
-8.5865%
5.1483%
-21.4644%
35.3052%
4.9358%
0.284%
-0.9385%
11.8017%
5.8934%
32.6019%
-7.3219%
3.8781%
6.2927%
25.0723%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.